NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines.
We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame.
Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers.
NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.

Biotechnology

NEC OncoImmunity AS

NEC OncoImmunity AS' headquarters in Oslo, Norway

This department focuses on designing, developing, and maintaining software applications and systems.

Software Development

The Bioinformatics & Data Science team at NEC OncoImmunity AS leverages advanced machine learning and bioinformatics techniques to analyze and interpret complex biological data. This team is responsible for developing and refining predictive models to identify immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. By integrating diverse datasets, they enable precise patient selection and the identification of optimal neoantigen targets, accelerating the development of tailored, clinically actionable cancer treatments.

Bioinformatics & Data Science

This department focuses on analyzing complex data to derive insights and drive decision-making through predictive modeling and statistical analysis.

Data Science

This department focuses on using computational techniques to analyze and interpret biological data.

Bioinformatics Department

The Leadership Team at NEC OncoImmunity AS is responsible for setting the strategic direction, overseeing major operational decisions, and ensuring alignment with the company's mission to advance personalized cancer immunotherapy and infectious disease vaccines. This team, comprising key executives such as the Chief Drug Development Officer, CEO & Co-founder, Chief Executive Officer, and Principal Bioinformatician, drives innovation, secures funding, and fosters collaborations to propel the company's AI-driven biotech solutions forward.

Leadership Team

This department oversees the development, quality, and compliance of products while managing associated risks.

People (3)

Jobs (0)

Other teams

Bioinformatics & Data Science

Data Science

Bioinformatics Department

Leadership Team

Product Management